Shares in Caliper Life Sciences fell nearly 10 percent for the five-day trading period ended Tuesday, despite the firm’s announcement last week that it had received a key patent allowance (see related article). The firm also reaffirmed its full-year revenue guidance of $137 million to $143 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.